Filing Details

Accession Number:
0001209191-23-050223
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-20 20:09:30
Reporting Period:
2023-09-18
Accepted Time:
2023-09-20 20:09:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
906709 Nektar Therapeutics NKTR Pharmaceutical Preparations (2834) 943134940
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1632901 Myriam Curet C/O Nektar Therapeutics
455 Mission Bay Blvd South, Suite 100
San Francisco CA 94158
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-09-18 4,359 $0.69 27,418 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Acquisiton 2023-09-19 85,000 $0.00 85,000 $0.68
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
85,000 2031-09-18 No 4 A Direct
Footnotes
  1. Represents the number of shares required to be sold by the reporting person to cover tax obligations in connection with the vesting of certain RSUs held by the reporting person. This sale is mandated by the reporting person's previous election under the Issuer's equity incentive plans to require the satisfaction of tax obligations to be funded by a "sell to cover" transaction.
  2. This stock option vests in equal monthly installments over the one-year period beginning on September 19, 2023.